Both in Medical Labs
Guardant Health vs GRAIL
Over the past year GH returned +76.9% and GRAL returned +55.3%; their daily moves had a correlation of 0.44.
GH +76.9% GRAL +55.3%Growth of $1, one year, split-adjusted
| Metric | GH | GRAL |
|---|---|---|
| Price | $175.00 | $139.44 |
| Market cap | $23.48B | $6.23B |
| Today | +2.50% | +4.25% |
| 1 month | −6.5% | −9.5% |
| 6 months | +95.5% | +156.3% |
| Year to date | +71.3% | +62.9% |
| 1 year | +88.1% | — |
| Revenue growth (YoY) | +44.3% | +25.7% |
| Gross margin | 65.4% | −28.1% |
| Net margin | −35.9% | −246.7% |
| P/E (TTM) | — | — |
| Price / sales | 19.8× | 37.7× |
| Net cash | -$449.5M | $861.6M |
| Dividend yield | — | — |
| Volatility (60d) | 44.4% | 97.6% |
| Short % of float | 9.2% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).